Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Millions of patients who take the blood-thinning drug Warfarin could soon use a home testing kit to measure the thickness of their own blood. This portable device, featuring a new micromechanical sensor, would make it far easier for these patients to safely treat themselves.

Warfarin is used to treat patients suffering from a range of conditions, from pulmonary embolism and heart conditions to thrombosis and excessive blood clotting. But the drug’s use needs to be constantly monitored because of a tendency to react with other drugs and metabolic molecules, says John Curtis, chief executive of MicroVisk, the U.K.-based company behind the new device. Diet, alcohol consumption, exercise, and infection can all influence Warfarin’s effectiveness, and hence the body’s ability to form clots. To avoid the risk of severe internal or external bleeding, drug doses must be managed carefully through regular monitoring of blood coagulation.

Usually, this means taking a blood sample at a doctor’s office, sending it off for laboratory testing, and waiting weeks for the results. MicroVisk’s aim is to provide a point-of-care or home testing kit that works almost instantly with the same accuracy, Curtis says.

Coagulation is normally measured by recording the thickness of blood at 100-millisecond intervals after adding a reagent called thromboplastin that initiates coagulation. In the lab, this is done by measuring the way that light scatters through a blood sample. But MicroVisk achieves the same result using a pair of vibrating cantilevers, which are immersed in a blood sample and vibrated quickly.

The device consists of a micro-electromechanical system (MEMS) made up of two 600-micrometer-long cantilevers. These silicon-based devices contain multiple layers of a conducting polymer and a separate piezoelectric material that is coiled along the length of each cantilever. “When we run a current through the conductor, it heats the coils, which causes them to flex,” says Curtis. Pulsing current through the coils makes the cantilevers vibrate, while the piezoelectric coils generate a small current that reveals how much they flex.

Two cantilevers are needed, Curtis explains, because one samples the blood directly, while the other detects background vibrations that are subtracted to cancel out vibrations in the surrounding environment.

4 comments. Share your thoughts »

Credit: MicroVisk

Tagged: Biomedicine, blood, MEMS

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me